Dr. Reda Ibrahim, MD
Claim this profileInstitut de Cardiologie de Montreal (Montreal Heart Inst.)
Studies Stroke
Studies Patent Foramen Ovale
9 reported clinical trials
18 drugs studied
Affiliated Hospitals
Clinical Trials Reda Ibrahim, MD is currently running
AMPLATZER PFO Occluder
for Patent Foramen Ovale
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
Recruiting1 award N/A1 criteria
PFO Closure Devices
for Stroke Prevention
The objective of this study is to investigate whether percutaneous PFO closure with the Occlutech Flex II PFO Occluder is non-inferior to the AMPLATZER™ PFO Occluder and Gore® Cardioform Septal Occluder in closure of the PFO, prevention of recurrent embolic stroke, and device/procedure related Serious Adverse Events (SAE).
Recruiting1 award N/A4 criteria
More about Reda Ibrahim, MD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Reda Ibrahim, MD has experience with
- Occlutech Figulla Flex II®
- AMPLATZER™ Septal Occluder
- GORE® CARDIOFORM ASD Occluder
- V-Wave Interatrial Shunt
- AMPLATZER™ PFO Occluder
- ACURATE Neo2™ Transfemoral TAVR System
Breakdown of trials Reda Ibrahim, MD has run
Stroke
Patent Foramen Ovale
Aortic Valve Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reda Ibrahim, MD specialize in?
Reda Ibrahim, MD focuses on Stroke and Patent Foramen Ovale. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Reda Ibrahim, MD currently recruiting for clinical trials?
Yes, Reda Ibrahim, MD is currently recruiting for 6 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Reda Ibrahim, MD has studied deeply?
Yes, Reda Ibrahim, MD has studied treatments such as Occlutech Figulla Flex II®, AMPLATZER™ Septal Occluder, GORE® CARDIOFORM ASD Occluder.
What is the best way to schedule an appointment with Reda Ibrahim, MD?
Apply for one of the trials that Reda Ibrahim, MD is conducting.
What is the office address of Reda Ibrahim, MD?
The office of Reda Ibrahim, MD is located at: Institut de Cardiologie de Montreal (Montreal Heart Inst.), Montréal, Quebec H1T 1C8 Canada. This is the address for their practice at the Institut de Cardiologie de Montreal (Montreal Heart Inst.).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.